CA2640986C - Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels - Google Patents

Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels Download PDF

Info

Publication number
CA2640986C
CA2640986C CA2640986A CA2640986A CA2640986C CA 2640986 C CA2640986 C CA 2640986C CA 2640986 A CA2640986 A CA 2640986A CA 2640986 A CA2640986 A CA 2640986A CA 2640986 C CA2640986 C CA 2640986C
Authority
CA
Canada
Prior art keywords
ocular
inhibitory
formulation
polypeptide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2640986A
Other languages
English (en)
Other versions
CA2640986A1 (fr
Inventor
Reza Dana
Mohammad Dastjerdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schepens Eye Research Institute Inc
Original Assignee
Schepens Eye Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schepens Eye Research Institute Inc filed Critical Schepens Eye Research Institute Inc
Priority claimed from PCT/US2008/009776 external-priority patent/WO2009025763A2/fr
Publication of CA2640986A1 publication Critical patent/CA2640986A1/fr
Application granted granted Critical
Publication of CA2640986C publication Critical patent/CA2640986C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition ayant les moyens d'inhiber la fonction de la cytokine de l'inflammation IL-I et des procédés d'utilisation de cette composition pour traiter une maladie inflammatoire des annexes et des tissus oculaires par administration topique. La présente invention décrit également des dispositifs permettant d'administrer cette composition à des tissus cibles.
CA2640986A 2007-08-16 2008-08-15 Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels Active CA2640986C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96513507P 2007-08-16 2007-08-16
US60/965,135 2007-08-16
US13068708P 2008-06-02 2008-06-02
US61/130,687 2008-06-02
PCT/US2008/009776 WO2009025763A2 (fr) 2007-08-16 2008-08-15 Composition thérapeutique pour le traitement de l'inflammation des annexes et des tissus oculaires

Publications (2)

Publication Number Publication Date
CA2640986A1 CA2640986A1 (fr) 2009-02-16
CA2640986C true CA2640986C (fr) 2014-10-21

Family

ID=40374879

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2640986A Active CA2640986C (fr) 2007-08-16 2008-08-15 Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels

Country Status (1)

Country Link
CA (1) CA2640986C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3673896T3 (da) * 2018-12-28 2022-02-07 Dr Rolf Lambert Pharma Consulting Gmbh Liposomal øjendråbeopløsning og anvendelser deraf til behandling af tørre øjne.

Also Published As

Publication number Publication date
CA2640986A1 (fr) 2009-02-16

Similar Documents

Publication Publication Date Title
US10105441B2 (en) Method for inhibiting or reducing dry eye disease by IL-1Ra
JP2011516400A5 (fr)
EP2242504B1 (fr) Compositions thérapeutiques utilisées pour le traitement des affections inflammatoires oculaires
AU2010203425B2 (en) Therapeutic compositions for treatment of corneal disorders
Colligris et al. Recent developments on dry eye disease treatment compounds
Costa et al. Wound healing modulation in glaucoma filtration surgery
Sherwood A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis)
US20120014970A1 (en) Therapeutic Compositions for Treatment of Corneal Disorders
CA2640986C (fr) Compositions therapeutiques pour le traitement de l'inflammation des tissus oculaires et annexiels
AU2014227534B2 (en) Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
WO2025027060A1 (fr) Facteur de transcription runx3 codé par un acide nucléique
CN114206849B (zh) 用于治疗非感染性眼部免疫炎性病症的治疗方法
US11306140B2 (en) Therapeutics for ocular immunoinflammatory diseases
EP3865132B1 (fr) Procédés et compositions pour réduire la perte de cellules endothéliales cornéennes
Gumus Topical Coenzyme Q10 Eye Drops as an Adjuvant Treatment in Challenging Refractory Corneal Ulcers: A Case Series and

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240809

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240809

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250808

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250808